Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Screening for thyroid cancer in patients with familial adenomatous polyposis.

Jarrar AM, Milas M, Mitchell J, Laguardia L, O'Malley M, Berber E, Siperstein A, Burke C, Church JM.

Ann Surg. 2011 Mar;253(3):515-21. doi: 10.1097/SLA.0b013e3181fcba8a.

PMID:
21173694
2.

Characteristics of benign and malignant thyroid disease in familial adenomatous polyposis patients and recommendations for disease surveillance.

Feng X, Milas M, O'Malley M, LaGuardia L, Berber E, Jin J, Metzger R, Mitchell J, Shin J, Burke CA, Kalady M, Church J, Siperstein A.

Thyroid. 2015 Mar;25(3):325-32. doi: 10.1089/thy.2014.0107. Epub 2015 Feb 9.

PMID:
25585202
3.

Screening for thyroid cancer in patients with familial adenomatous polyposis.

Cetta F, Ugolini G, Martellucci J, Gotti G.

Ann Surg. 2015 Jan;261(1):e13-4. doi: 10.1097/SLA.0000000000000442. No abstract available.

PMID:
24394556
4.

Results of a prospective thyroid ultrasound screening program in adenomatous polyposis patients.

Steinhagen E, Hui VW, Levy RA, Markowitz AJ, Fish S, Wong RJ, Sood R, Ochman SM, Guillem JG.

Am J Surg. 2014 Nov;208(5):764-9. doi: 10.1016/j.amjsurg.2014.03.012. Epub 2014 Jun 20.

PMID:
25073656
5.

Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations.

Herraiz M, Barbesino G, Faquin W, Chan-Smutko G, Patel D, Shannon KM, Daniels GH, Chung DC.

Clin Gastroenterol Hepatol. 2007 Mar;5(3):367-73. Epub 2007 Jan 26.

PMID:
17258512
6.

The prevalence of thyroid cancer and benign thyroid disease in patients with familial adenomatous polyposis may be higher than previously recognized.

Steinhagen E, Guillem JG, Chang G, Salo-Mullen EE, Shia J, Fish S, Stadler ZK, Markowitz AJ.

Clin Colorectal Cancer. 2012 Dec;11(4):304-8. doi: 10.1016/j.clcc.2012.01.006. Epub 2012 Mar 15.

PMID:
22425061
7.

Cribriform-morular variant of papillary thyroid carcinoma: ultrasonographic and clinical characteristics.

Chong Y, Shin JH, Oh YL, Han BK, Ko EY.

Thyroid. 2013 Jan;23(1):45-9. doi: 10.1089/thy.2011.0534. Epub 2012 Aug 14.

PMID:
22892017
8.

Risk of thyroid cancer among Caribbean Hispanic patients with familial adenomatous polyposis.

Casellas-Cabrera N, Díaz-Algorri Y, Carlo-Chévere VJ, González-Pons M, Rodríguez-Mañón N, Pérez-Mayoral J, Bertrán-Rodríguez C, Soto-Salgado M, Giardiello FM, Rodríguez-Quilichini S, Cruz-Correa M.

Fam Cancer. 2016 Apr;15(2):267-74. doi: 10.1007/s10689-015-9862-4.

9.

Cribriform variant papillary thyroid cancer: a characteristic of familial adenomatous polyposis.

Fenton PA, Clarke SE, Owen W, Hibbert J, Hodgson SV.

Thyroid. 2001 Feb;11(2):193-7.

PMID:
11288991
10.

Papillary thyroid carcinoma in three siblings with familial adenomatous polyposis.

Civitelli S, Tanzini G, Cetta F, Petracci M, Pacchiarotti MC, Civitelli B.

Int J Colorectal Dis. 1996;11(1):34-7.

PMID:
8919339
11.

Genotype and phenotype of patients with both familial adenomatous polyposis and thyroid carcinoma.

Truta B, Allen BA, Conrad PG, Kim YS, Berk T, Gallinger S, Bapat B, Terdiman JP, Sleisenger MH.

Fam Cancer. 2003;2(2):95-9.

PMID:
14574158
12.

[Familial adenomatous polyposis. Initial experiences with the Heidelberg polyposis register].

Möslein G, Buhr HJ, Kadmon M, Herfarth C.

Chirurg. 1992 Apr;63(4):327-33. German.

PMID:
1317773
13.
14.

The natural history of familial adenomatous polyposis syndrome: a 24 year review of a single center experience in screening, diagnosis, and outcomes.

Kennedy RD, Potter DD, Moir CR, El-Youssef M.

J Pediatr Surg. 2014 Jan;49(1):82-6. doi: 10.1016/j.jpedsurg.2013.09.033. Epub 2013 Oct 5.

PMID:
24439586
15.

Prospective screening in familial nonmedullary thyroid cancer.

Sadowski SM, He M, Gesuwan K, Gulati N, Celi F, Merino MJ, Nilubol N, Kebebew E.

Surgery. 2013 Dec;154(6):1194-8. doi: 10.1016/j.surg.2013.06.019. Epub 2013 Aug 23.

16.

Genetic alterations in thyroid carcinoma associated with familial adenomatous polyposis: clinical implications and suggestions for early detection.

Cetta F, Olschwang S, Petracci M, Montalto G, Baldi C, Zuckermann M, Mariani Costantini R, Fusco A.

World J Surg. 1998 Dec;22(12):1231-6.

PMID:
9841749
17.

Clinical characterization and mutation spectrum in Hispanic families with adenomatous polyposis syndromes.

Cruz-Correa M, Diaz-Algorri Y, Mendez V, Vazquez PJ, Lozada ME, Freyre K, Lathroum L, Gonzalez-Pons M, Hernandez-Marrero J, Giardiello F, Rodriguez-Quilichini S.

Fam Cancer. 2013 Sep;12(3):555-62. doi: 10.1007/s10689-013-9617-z.

18.

Occurrence of thyroid carcinoma in Dutch patients with familial adenomatous polyposis. An epidemiological study and report of new cases.

van der Linde K, Vasen HF, van Vliet AC.

Eur J Gastroenterol Hepatol. 1998 Sep;10(9):777-81.

PMID:
9831273
19.

Nuclear localization of immunoreactive beta-catenin is specific to familial adenomatous polyposis in papillary thyroid carcinoma.

Kurihara K, Shimizu S, Chong J, Hishima T, Funata N, Kashiwagi H, Nagai H, Miyaki M, Fukayama M.

Jpn J Cancer Res. 2000 Nov;91(11):1100-2.

PMID:
11092973
20.

Familial adenomatous polyposis at the Tel Aviv Medical Center: demographic and clinical features.

Rozen P, Samuel Z, Rabau M, Goldman G, Shomrat R, Legum C, Orr-Urtreger A.

Fam Cancer. 2001;1(2):75-82.

PMID:
14574001

Supplemental Content

Support Center